Cerus Corporation

438 articles about Cerus Corporation

• Cerus Corporation to Participate in Upcoming November 2023 Investor Conferences

  11/3/2023

  Cerus Corporation announced that the Company will participate in two upcoming investor conferences.

• Cerus Corporation Announces Third Quarter 2023 Financial Results

  11/2/2023

  Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2023.

• Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

  10/19/2023

  Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2023 financial results will be released on Thursday, November 2, 2023, after the close of the stock market.

• Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

  9/27/2023

  Cerus Corporation (Nasdaq: CERS) announced today that Alicia Goodman has been appointed to the role of Chief Human Resources Officer (CHRO).

• Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

  9/12/2023

  Cerus Corporation (Nasdaq: CERS) announced today that Kevin Green, Cerus’ chief financial officer, is scheduled to participate at the 2023 Cantor Global Healthcare Conference on Tuesday, September 26, at 10:30 a.m. EST.

• Cerus Corporation Announces Second Quarter 2023 Financial Results

  8/2/2023

  Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.

• Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023

  7/19/2023

  Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2023 financial results will be released on Wednesday, August 2, 2023, after the close of the stock market.

• Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress

  6/15/2023

  Cerus Corporation announced a selection of abstracts and a lunch symposium at the 33rd Regional International Society of Blood Transfusion Congress, taking place in Gothenburg, Sweden, from June 17 through June 21.

• Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

  6/5/2023

  Cerus Corporation (Nasdaq: CERS) today announced that it has been awarded an additional $8.7 million contract amendment to the original $9.1 million contract by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the development of pathogen.

• Cerus Corporation Announces First Quarter 2023 Financial Results

  5/4/2023

  Cerus Corporation announced financial results for the first quarter ended March 31, 2023.

• Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

  4/20/2023

  Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on Thursday, May 4, 2023, after the close of the stock market.

• Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results

  2/28/2023

  Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and full year ended December 31, 2022.

• Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

  2/15/2023

  Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full year 2022 financial results will be released on Tuesday, February 28, 2023, after the close of the stock market.

• Cerus Corporation to Participate in Upcoming Investor Conferences - February 10, 2023

  2/10/2023

  Cerus Corporation announced that the Company will participate in two upcoming investor conferences.

• Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update

  1/9/2023

  Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2022 and provided product revenue guidance for full-year 2023.

• Cerus Corporation to Participate in Upcoming November 2022 Investor Conferences

  11/4/2022

  Cerus Corporation announced that Vivek Jayaraman, Cerus’ chief operating officer, is scheduled to participate in two conferences.

• Cerus Corporation Announces Third Quarter 2022 Financial Results

  11/3/2022

  Cerus Corporation announced financial results for the third quarter ended September 30, 2022.

• Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

  11/2/2022

  Cerus Corporation announced that it has been awarded a $9.1 million contract by the U.S. Department of Defense Industrial Base Analysis and Sustainment program for the development of pathogen reduced, lyophilized cryoprecipitate to treat bleeding due to trauma.

• Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage

  11/1/2022

  Cerus Corporation (Nasdaq:CERS) today announced it has received approval from Health Canada to extend the storage of platelets treated with the INTERCEPT Blood System from five days to seven days from the time of collection, joining other territories where INTERCEPT platelets are approved for seven-day storage.

• Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022

  10/20/2022

  Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2022 financial results will be released on Thursday, November 3, 2022, after the close of the stock market.